Emerging changes in prostate cancer screening and treatment

Abstract

Screening geared to early detection in almost every case carries the risk of overdiagnosis. This may result in overtreatment, which can reduce quality of life. Three contri­butions provide guidance as to how to reduce dramatically the harms of screening. If utilised, these should result in the rehabilitation’ of screening and reduce prostate cancer mortality at an acceptable cost.